The University of Otago’s Centre for International Health has announced it's joining a major global trial studying the effectiveness of a new treatment for latent tuberculosis.

Centre researchers and their collaborators at the University of Padjadjaran have also gained around $540,000 in funding to run an arm of the clinical trial in Bandung, Indonesia.

Centre Director, Professor Philip Hill, says the World Health Organization estimates that approximately one-third of the world’s entire population are carriers of the latent form of tuberculosis, and says that the study has the potential to eradicate the disease.

Email page link

Story feedback

Buy on DVD